Home・Akcijų sąrašas・Pharma Mar SA

P
Pharma Mar SA

Atidarymo kaina

79.1 0.76

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

78.4

Max

80.1

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-58M 1.6M
Pardavimai	-48M 43M
P/E Sektoriaus vid.	17.175 64.641
Pelnas, tenkantis vienai akcijai	0.088
Pelno marža	3.725
Darbuotojai	505
EBITDA	-40M 2.7M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+27.63% upside

Dividendai
By Acuity
Kitas uždarbis	2026-10-29

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-280M 1.4B
Ankstesnė atidarymo kaina	78.34
Ankstesnė uždarymo kaina	79.1

Pharma Mar SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-03 23:56; UTC

Full Truck Alliance Co Ltd. is trading higher in after-market hours, reflecting routine fluctuations within a narrow range above its 20-day moving average.

2026-08-03 23:56; UTC

State Street Corp shares are trading lower in after-market hours, following a modest decline after Monday's regular session close.

2026-08-03 23:56; UTC

Pentair PLC shares are lower in after-market hours with no specific news driving the decline. The stock remains within its one-month trading range.

2026-08-03 23:56; UTC

News

Diversified Healthcare Trust reported second-quarter FFO of $0.16, exceeding estimates. Revenue fell short at $365.39 million, contributing to a decline in after-market trading.

2026-08-03 23:56; UTC

Correlated Moves

Masco Corp shares are higher in after-market trading, supported by a notable rise in JELD-WEN Holding Inc. The stock remains near its one-month range low.

2026-08-03 23:56; UTC

Stanley Black & Decker shares are higher in after-market trading, supported by positive market sentiment and easing inflation concerns amid declining oil prices.

2026-08-03 23:56; UTC

Correlated Moves

Microstrategy Inc shares declined after market hours, reaching a low of -1.10%. The drop may be influenced by Bitcoin's recent decline.

2026-08-03 23:56; UTC

Chewy Inc. shares are trading higher in after-market hours, rebounding from a brief dip following Monday's close amid broader positive market sentiment.

2026-08-03 23:56; UTC

Kroger Co shares are lower in after-market trading, retracing from an earlier rise and settling around the midpoint of their one-month trading range.

2026-08-03 23:56; UTC

MGM Resorts International shares are higher in after-market hours, continuing modest gains since Monday's close amid positive sentiment in European markets.

2026-08-03 23:56; UTC

Equinix Inc shares are higher in after-market hours, reflecting broader market strength amid gains in European indices and falling oil prices.

2026-08-03 23:56; UTC

Correlated Moves

Martin Marietta Materials shares are higher in after-market trading, supported by positive market sentiment and correlated gains in nVent Electric PLC.

2026-08-03 23:56; UTC

Incyte Corp shares are higher in after-market hours, recovering from five consecutive daily declines. Broader market sentiment remains positive amid declining oil prices.

2026-08-03 23:56; UTC

Brown & Brown Inc shares are trading lower in after-market hours, following a session that included an early spike before a steady decline.

2026-08-03 23:56; UTC

AutoZone Inc shares are trading higher in after-market hours, recovering from a dip after Monday's close with no specific news identified for the movement.

2026-08-03 23:56; UTC

J M Smucker Co shares are higher in after-market hours, recovering from earlier declines and remaining above their 20-day moving average. No specific news was identified.

2026-08-03 23:56; UTC

ETF Constituents

The iShares China Large-Cap ETF is trading roughly flat in after-market hours, supported by LI's positive return and JD's slight decline.

2026-08-03 23:56; UTC

Correlated Moves

NIO Inc shares are higher in after-market trading, reflecting positive sentiment in the electric vehicle sector. Xpeng Inc also saw a price increase.

2026-08-03 23:56; UTC

JPMorgan Chase & Co shares are higher in after-market hours, supported by positive sentiment in European markets. The asset remains above its 20-day moving average.

2026-08-03 23:56; UTC

Bath & Body Works Inc. shares declined slightly in after-market trading, reflecting routine fluctuations despite remaining above the 20-day moving average.

2026-08-03 23:56; UTC

News

First Solar Inc reported second-quarter revenue of $1.06 billion and a net profit of $423 million. Shares are higher in after-hours trading.

2026-08-03 23:56; UTC

Cisco Systems Inc shares are lower in after-market hours, with no specific news identified to explain the decline. The broader market showed mixed signals.

2026-08-03 23:56; UTC

Indie Semiconductor Inc. shares are higher in after-market trading, showing modest gains since Monday's close amid positive broader market sentiment.

2026-08-03 23:56; UTC

Correlated Moves

Riot Platforms Inc. is higher in after-market hours, recovering from an initial dip. Positive sentiment in European indices supports cryptocurrency-related stocks.

2026-08-03 23:56; UTC

Correlated Moves

Kosmos Energy Ltd shares are higher in after-hours trading, reflecting positive sentiment in the energy sector and influenced by Crescent Energy's notable gains.

2026-08-03 23:56; UTC

New Fortress Energy Inc shares are higher in after-market trading, reflecting a recovery from earlier lows amid positive sentiment in European markets.

2026-08-03 23:56; UTC

Macro News

Crude oil prices are lower as President Trump called off a military strike on Iran, boosting optimism for stability in the Middle East.

2026-08-03 23:52; UTC

Social Media

Correlated Moves

News

Microsoft shares are lower in after-market hours amid a class action lawsuit alleging misrepresentation of its Copilot products' performance and competitive position.

2026-08-03 23:51; UTC

Schneider National shares higher in after-market trading, reflecting notable strength since Monday's close despite remaining below the 20-day moving average.

2026-08-03 23:51; UTC

Shake Shack Inc. shares declined after-market, contrasting with gains in major U.S. tech stocks. The asset remains above its 20-day moving average.

Akcijų palyginimas

Kainos pokytis

Pharma Mar SA Prognozė

Kainos tikslas

By TipRanks

27.63% į viršų

12 mėnesių prognozė

Vidutinis 100.001 EUR 27.63%

Aukščiausias 100 EUR

Žemiausias 100 EUR

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Pharma Mar SA kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

Pirkti

Laikyti

Parduoti

Remiantis 1 analitikų, pateikusių Pharma Mar SA akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Pharma Mar SA

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca to treat patients with small cell lung cancer. The company develops Ecubectedin (PM14), which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trials for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trials for treating solid tumors; PM54, which is in Phase I clinical trials for the treatment of solid tumors; SYL1801 that is in phase II clinical trials for treating macular degeneration; SYL116011, which is in preclinical studies for the treatment of ocular allergies; and SYL A and B that is in investigational studies to treat retinitis pigmentosa. In addition, it engages in the research, development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.